We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITCI
3751
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.42M ﹤0.01%
138,900
-65,400
-32% -$1.72M
HBI
3752
PUT
DELISTED
Hanesbrands
HBI
$4.42M ﹤0.01%
302,900
+1,800
+0.6% +$27.2K
IWD icon
3753
PUT
iShares Russell 1000 Value ETF
IWD
$83.2B
$4.42M ﹤0.01%
32,300
-16,800
-34% -$2.15M
DFS
3754
DELISTED
Discover Financial Services
DFS
$4.41M ﹤0.01%
48,760
-72,497
-60% -$5.41M
BTI icon
3755
CALL
British American Tobacco
BTI
$127B
$4.41M ﹤0.01%
117,700
+15,900
+16% +$569K
TSN icon
3756
Tyson Foods
TSN
$20.6B
$4.41M ﹤0.01%
68,441
-788,426
-92% -$49M
NBIX icon
3757
CALL
Neurocrine Biosciences
NBIX
$16.2B
$4.41M ﹤0.01%
46,000
-13,200
-22% -$1.27M
FLWS icon
3758
1-800-Flowers.com
FLWS
$258M
$4.41M ﹤0.01%
169,530
+94,126
+125% +$2.29M
ACB
3759
PUT
Aurora Cannabis
ACB
$185M
$4.41M ﹤0.01%
53,010
+29,470
+125% +$2.15M
ADPT icon
3760
CALL
Adaptive Biotechnologies
ADPT
$3.75B
$4.41M ﹤0.01%
74,500
+20,300
+37% +$1.05M
FSDC
3761
DELISTED
FS Development Corp. Class A Common Stock
FSDC
$4.4M ﹤0.01%
400,000
FIZZ icon
3762
PUT
National Beverage
FIZZ
$2.99B
$4.4M ﹤0.01%
103,600
+6,400
+7% +$275K
BWA icon
3763
CALL
BorgWarner
BWA
$13.5B
$4.39M ﹤0.01%
129,129
-89,778
-41% -$3.04M
LTHM
3764
CALL
DELISTED
Livent Corporation
LTHM
$4.39M ﹤0.01%
233,000
+117,700
+102% +$1.64M
WMS icon
3765
Advanced Drainage Systems
WMS
$11.4B
$4.39M ﹤0.01%
52,503
+4,187
+9% +$297K
AIA icon
3766
iShares Asia 50 ETF
AIA
$4.7B
$4.39M ﹤0.01%
+50,317
New +$4.02M
FVRR icon
3767
Fiverr
FVRR
$331M
$4.39M ﹤0.01%
22,479
-13,939
-38% -$2.52M
PHO icon
3768
Invesco Water Resources ETF
PHO
$2.08B
$4.38M ﹤0.01%
94,398
-34,675
-27% -$1.52M
PVG
3769
PUT
DELISTED
PRETIUM RESOURCES INC.
PVG
$4.38M ﹤0.01%
381,700
+203,800
+115% +$2.45M
GNCA
3770
DELISTED
Genocea Biosciences, Inc.
GNCA
$4.38M ﹤0.01%
1,808,732
+10,729
+0.6% +$24.4K
SNDR icon
3771
Schneider National
SNDR
$6.17B
$4.38M ﹤0.01%
+211,421
New +$4.73M
MASI
3772
PUT
DELISTED
Masimo
MASI
$4.38M ﹤0.01%
16,300
-8,800
-35% -$2.19M
IBUY icon
3773
Amplify Online Retail ETF
IBUY
$109M
$4.37M ﹤0.01%
38,258
+8,390
+28% +$853K
ESS icon
3774
CALL
Essex Property Trust
ESS
$18.3B
$4.37M ﹤0.01%
18,400
+6,300
+52% +$1.45M
SCI icon
3775
CALL
Service Corp International
SCI
$11.6B
$4.37M ﹤0.01%
88,900
+74,400
+513% +$3.53M

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.